| scholarly article | Q13442814 |
| P50 | author | Yae Kurosawa | Q90178593 |
| P2093 | author name string | Masato Taoka | |
| Shigehiro Sato | |||
| Tsuneo Okuyama | |||
| P2860 | cites work | Purification and immunogenicity study of human papillomavirus 58 virus-like particles expressed in Pichia pastoris | Q33984423 |
| Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus | Q34118664 | ||
| Modulation of poliovirus replicative fitness in HeLa cells by deoptimization of synonymous codon usage in the capsid region. | Q34545765 | ||
| Scanning electron microscopy-based approach to understand the mechanism underlying the adhesion of dengue viruses on ceramic hydroxyapatite columns | Q34551890 | ||
| Downstream processing of viral vectors and vaccines | Q36288881 | ||
| Clinical development of a novel inactivated poliomyelitis vaccine based on attenuated Sabin poliovirus strains | Q37878482 | ||
| "Guidance for industry: content and format of chemistry, manufacturing and controls information and establishment description information for a biological in vitro diagnostic product;" availability. Food and Drug Administration, HHS. Notice | Q73172432 | ||
| [Poliovirus vaccine] | Q85559098 | ||
| Isolation and purification of recombinant proteins, antibodies and plasmid DNA with hydroxyapatite chromatography | Q37965456 | ||
| Engineering adeno-associated viruses for clinical gene therapy | Q38212776 | ||
| Improved purification of recombinant adenoviral vector by metal affinity membrane chromatography | Q39908906 | ||
| Scaleable chromatographic purification process for recombinant adeno-associated virus (rAAV). | Q40825421 | ||
| An improved anion-exchange HPLC method for the detection and purification of adenoviral particles | Q40871239 | ||
| Strategies for the isolation and purification of retroviral vectors for gene therapy. | Q40954804 | ||
| Stability of hemagglutinating activity of extracellular and intracellular forms of Japanese encephalitis virus exposed to acidic pH. | Q41249174 | ||
| Purification of a type 5 recombinant adenovirus encoding human p53 by column chromatography | Q41275967 | ||
| A simple method for obtaining highly viable virus from culture supernatant | Q41485113 | ||
| Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain | Q42280576 | ||
| Size-exclusion chromatography as a linear transfer system: purification of human influenza virus as an example. | Q43493158 | ||
| Phase II and III Clinical Studies of Diphtheria-Tetanus-Acellular Pertussis Vaccine Containing Inactivated Polio Vaccine Derived from Sabin Strains (DTaP-sIPV). | Q44719516 | ||
| Purification of a functional gene therapy vector derived from Moloney murine leukaemia virus using membrane filtration and ceramic hydroxyapatite chromatography. | Q45730698 | ||
| Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield | Q45747699 | ||
| Review: Oncolytic virotherapy, updates and future directions | Q47160989 | ||
| Hydroxyapatite chromatography of phage-display virions | Q56894806 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 9 | |
| P921 | main subject | Poliovirus | Q70923324 |
| P304 | page(s) | e0222199 | |
| P577 | publication date | 2019-09-19 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Sequential two-step chromatographic purification of infectious poliovirus using ceramic fluoroapatite and ceramic hydroxyapatite columns | |
| P478 | volume | 14 |
| Q80666245 | Extraction of Hydroxyapatite Nanostructures from Marine Wastes for the Fabrication of Biopolymer-Based Porous Scaffolds | cites work | P2860 |
Search more.